GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (HKSE:00853) » Definitions » Cash Flow from Financing

MicroPort Scientific (HKSE:00853) Cash Flow from Financing : HK$3,399 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is MicroPort Scientific Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, MicroPort Scientific received HK$46 Mil more from issuing new shares than it paid to buy back shares. It received HK$1,057 Mil from issuing more debt. It paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0 Mil from paying cash dividends to shareholders. It received HK$1,683 Mil on other financial activities. In all, MicroPort Scientific earned HK$2,786 Mil on financial activities for the six months ended in Dec. 2023.


MicroPort Scientific Cash Flow from Financing Historical Data

The historical data trend for MicroPort Scientific's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific Cash Flow from Financing Chart

MicroPort Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,618.35 6,565.02 12,948.43 2,125.38 3,396.46

MicroPort Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,024.66 309.86 1,818.00 745.24 2,653.43

MicroPort Scientific Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

MicroPort Scientific's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

MicroPort Scientific's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$3,399 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort Scientific  (HKSE:00853) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

MicroPort Scientific's issuance of stock for the six months ended in Dec. 2023 was HK$46 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

MicroPort Scientific's repurchase of stock for the six months ended in Dec. 2023 was HK$0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

MicroPort Scientific's net issuance of debt for the six months ended in Dec. 2023 was HK$1,057 Mil. MicroPort Scientific received HK$1,057 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

MicroPort Scientific's net issuance of preferred for the six months ended in Dec. 2023 was HK$0 Mil. MicroPort Scientific paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

MicroPort Scientific's cash flow for dividends for the six months ended in Dec. 2023 was HK$0 Mil. MicroPort Scientific received HK$0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

MicroPort Scientific's other financing for the six months ended in Dec. 2023 was HK$1,683 Mil. MicroPort Scientific received HK$1,683 Mil on other financial activities.


MicroPort Scientific Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort Scientific (HKSE:00853) Business Description

Traded in Other Exchanges
Address
1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.
Executives
Shang Hai Zhang Jiang Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Maxwell Maxcare Science Foundation Limited 2201 Interest of corporation controlled by you
We'tron Capital Limited 2101 Beneficial owner
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hfty I Holdings Pte. Ltd. 2101 Beneficial owner
Otsuka Holdings Co., Ltd.
Otsuka Medical Devices Co., Ltd.
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

MicroPort Scientific (HKSE:00853) Headlines

No Headlines